Recent Technological and Pharmacological Advances in Type 1 Diabetes

Authors: Nitesh D Kuhadiya*

DOI: 10.23880/doij-16000122

Volume 1, Issue 2

Abstract

A vast majority of patients with type1 diabetes (T1D) are not at the glycemic goal of an HbA1c of less than 7%. It continues to remain a very tough disease and the patients often get very frustrated while managing the unpredictable fluctuations of blood glucose coupled with emotional volatility.

Keywords: Type 1 Diabetes; GLP-1 agents; SGLT-2 Inhibitors; Glucagon; Triple Therapy; Ketosis; Diabetic Ketoacidosis (DKA); Continuous Glucose Monitoring (CGM); Insulin pump; Closed Loop System

View PDF